| Metric | შპს ნეოფარმი + | შპს აიტი-დისტრიბუშენი | შპს მედელ საქართველო | შპს თბილისი მედიკ |
|---|---|---|---|---|
| Growth | ||||
| Revenue | ₾16.8m₾16.6m | ₾16.3m₾4.7m | ₾8.0m₾14.1m | ₾15.1m₾13.9m |
| Revenue growth | 1.5% | 246.9% | -43.0% | 8.8% |
| Profitability | ||||
| EBITDA | ₾469k₾506k | ₾1.5m₾673k | ₾3.5m₾5.9m | ₾3.1m₾5.8m |
| EBITDA margin | 2.8%3.1% | 9.3%14.3% | 43.9%41.9% | 20.3%41.8% |
| Net profit | ₾447k₾494k | ₾1.2m₾458k | ₾3.5m₾6.5m | ₾3.0m₾5.8m |
| Net margin | 2.7%3.0% | 7.4%9.8% | 43.1%46.2% | 19.8%41.9% |
| Balance sheet | ||||
| Total assets | ₾5.7m₾5.1m | ₾10.7m₾3.2m | ₾1.1m₾438k | ₾13.1m₾11.9m |
| Total equity | ₾1.9m₾1.5m | ₾1.7m₾508k | ₾1000k₾268k | ₾12.0m₾11.0m |
| ROE | 23.6%34.1% | 70.5%90.2% | 345.6%2422.0% | 24.9%52.8% |